Luzitin

Your wellness matters

Big Idea

A game-changing new generation of photosensitizers (Redaporfin) in the Oncology field, which can bring photodynamic therapy (PDT) into routine daily practice for the targeted therapy of solid tumours.

Year Invested

2010

Sector

Pharma / Biotech

Stage

Clinical Development stage

Team

Sérgio Simões – Chairman & CEO; Cláudia Silva – COO/Deputy CEO; Luis Almeida – Chief Medical Officer; Tobias Silva – Business Development.

Portugal Ventures Investment Manager

Miguel Botto